CVS Group Plc (LON:CVSG) price target lowered to GBX 1,180 by Royal Bank of Canada

0

Analyst Ratings For CVS Group Plc (LON:CVSG)

Today, Royal Bank of Canada lowered its price target on CVS Group Plc (LON:CVSG) to GBX 1,180 per share.

There are 3 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.

The current consensus rating on CVS Group Plc (LON:CVSG) is Buy with a consensus target price of GBX 1,260 per share, a potential .

Some recent analyst ratings include

  • 10/3/2018-CVS Group Plc (LON:CVSG) had its Buy rating reiterated by Peel Hunt
  • 11/24/2016-CVS Group Plc (LON:CVSG) had its Corporate rating reiterated by N+1 Singer


    About CVS Group Plc (LON:CVSG)
    CVS Group plc provides veterinary services in the United Kingdom. The company operates through four segments: Veterinary Practice, Laboratory, Crematoria, and Animed Direct. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste collection services for veterinary practices and directly for pet owners. In addition, it operates Animed Direct, an online pharmacy and retailer that sells prescription drugs, non-prescription drugs, pet food, and other animal-related products. Further, the company is involved in veterinary goods and services buying club businesses; the provision of burial grounds and recruitment services for veterinary jobs; and veterinary instrumentation supply activities. It owns 422 surgeries, 4 diagnostic laboratories, and 7 pet crematoria in the United Kingdom; and 10 surgeries in the Netherlands. CVS Group plc was founded in 1999 and is based in Diss, the United Kingdom.

    Recent Trading Activity for CVS Group Plc (LON:CVSG)
    Shares of CVS Group Plc closed the previous trading session at 835.50 up +5.50 0.66% with shares trading hands.